EyeFox Interview with Bence György: Base Editing for Stargardt Disease
- gyorgyben
- Jun 8
- 1 min read
EyeFox, Europe’s leading online portal for ophthalmology, recently published an interview with Bence György, Group Leader at the Institute of Molecular and Clinical Ophthalmology Basel (IOB).
In the interview, Bence György discusses why Stargardt disease is particularly well-suited for gene therapy approaches, and how a novel and highly precise gene editing technology - base editing - may offer a path toward treatment. He also outlines the preparatory steps currently underway at IOB to enable future clinical studies.
The interview is part of EyeFox’s commitment to showcasing impactful research in the field of ophthalmology and giving visibility to translational advances in Europe.
Comments